Logo - International Journal of Pharmaceutical Compounding

Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2019 - Volume 23, Number 6
View All Articles in Issue

Abstract:  A formulation for preparing Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, gabapentin, gabapentinoid, voltage-dependent calcium channel inhibitor, anticonvulsant agent, seizure disorder, epilepsy, headache, hiccups, neurological disorders, neuromuscular disorders, diabetic neuropathy, postoperative pain, chronic pain, neuropathic pain

Related Categories: EXCIPIENTS, FORMULATIONS, PAIN MANAGEMENT, MUSCULOSKELETAL DISORDERS, NEUROLOGY

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4689

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products